Brett Nanigian - Feb 3, 2022 Form 3 Insider Report for AutoWeb, Inc. (AUTO)

Role: SVP, Product & Technology
Signature: /s/ Glenn E. Fuller, Attorney-in-Fact
Stock symbol: AUTO
Transactions as of: Feb 3, 2022
Transactions value $: $0
Form type: 3
Date filed: 2/11/2022, 04:40 PM
Next filing: Sep 2, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	AUTO	Common Stock						6.4K	Feb 3, 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
holding	AUTO	Employee Stock Options (Right to Buy)							Feb 3, 2022	Common Stock	30K	$3.30	Direct	F1
holding	AUTO	Employee Stock Options (Right to Buy)							Feb 3, 2022	Common Stock	30K	$2.00	Direct	F2
holding	AUTO	Employee Stock Options (Right to Buy)							Feb 3, 2022	Common Stock	30K	$2.57	Direct	F3
holding	AUTO	Employee Stock Options (Right to Buy)							Feb 3, 2022	Common Stock	25K	$2.63	Direct	F4
holding	AUTO	Employee Stock Option (Right to Buy)							Feb 3, 2022	Common Stock	65K	$2.79	Direct	F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Grant on April 17, 2019, to reporting person of options to buy shares of common stock in transaction exempt under Rule 16b-3. These options will become vested and exercisable as follows: (i) 33 1/3% (adjusted to avoid the vesting of fractional options) vested and became exercisable on April 17, 2020, and (ii) 1/36 (adjusted monthly to avoid the vesting of fractional options in any month) shall vest and become exercisable on each successive monthly anniversary thereafter for the following 24 months ending April 17, 2022.
F2	Grant on February 26, 2020, to reporting person of options to buy shares of common stock in transaction exempt under Rule 16b-3. These options will become vested and exercisable as follows: (i) 33 1/3% (adjusted to avoid the vesting of fractional options) vested and became exercisable on February 26, 2021, and (ii) 1/36 (adjusted monthly to avoid the vesting of fractional options in any month) shall vest and become exercisable on each successive monthly anniversary thereafter for the following 24 months ending February 26, 2023.
F3	Grant on February 26, 2021, to reporting person of options to buy shares of common stock in transaction exempt under Rule 16b-3. These options will become vested and exercisable as follows: (i) 33 1/3% (adjusted to avoid the vesting of fractional options) shall vest and become exercisable on February 26, 2022, and (ii) 1/36 (adjusted monthly to avoid the vesting of fractional options in any month) shall vest and become exercisable on each successive monthly anniversary thereafter for the following 24 months ending February 26, 2024.
F4	Grant on August 25, 2021, to reporting person of options to buy shares of common stock in transaction exempt under Rule 16b-3. These options will become vested and exercisable as follows: (i) 33 1/3% (adjusted to avoid the vesting of fractional options) shall vest and become exercisable on August 25, 2022, and (ii) 1/36 (adjusted monthly to avoid the vesting of fractional options in any month) shall vest and become exercisable on each successive monthly anniversary thereafter for the following 24 months ending August 25, 2024.
F5	Grant on February 3, 2022, to reporting person of options to buy shares of common stock in transaction exempt under Rule 16b-3. These options will become vested and exercisable as follows: (i) 33 1/3% (adjusted to avoid the vesting of fractional options) shall vest and become exercisable on February 3, 2023, and (ii) 1/36 (adjusted monthly to avoid the vesting of fractional options in any month) shall vest and become exercisable on each successive monthly anniversary thereafter for the following 24 months ending February 3, 2025.